Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Mira Pharmaceuticals' drug Ketamir-2 reversed PTSD symptoms in animals and may advance to human trials.
MIRA Pharmaceuticals reports that its oral drug candidate Ketamir-2 restored normal behavior in animals within a validated PTSD model, reversing stress-related symptoms like despair and avoidance.
The results support expanding evaluation into neuropsychiatric disorders, including PTSD, following promising safety data from a Phase 1 trial for neuropathic pain.
The company plans to explore collaborations with military and government entities to address the significant unmet need for effective PTSD treatments, with a larger follow-on study underway.
3 Articles
El fármaco Ketamir-2 de Mira Pharmaceuticals revirtió los síntomas de TEPT en animales y puede avanzar a los ensayos en humanos.